BAQSIMI

This brand name is authorized in Austria, Canada, Cyprus, Estonia, Spain, Finland, France, Croatia, Ireland, Japan, Lithuania, Netherlands, Poland, Romania, United States

Active ingredients

The drug BAQSIMI contains one active pharmaceutical ingredient (API):

1 Glucagon UNII 1H87NVF4DB - GLUCAGON HYDROCHLORIDE

Glucagon is a hyperglycaemic agent that mobilises hepatic glycogen, which is released into the blood as glucose. Glucagon inhibits the tone and motility of the smooth muscle in the gastrointestinal tract. Read about Glucagon

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
H04AA01	Glucagon	H Systemic hormonal preparations, excl. Sex hormones and insulins → H04 Pancreatic hormones → H04A Glycogenolytic hormones → H04AA Glycogenolytic hormones
Discover more medicines within H04AA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02492415
Country: EE	Ravimiamet	Identifier(s): 1809176, 1809187
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1191406001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 129450
Country: FR	Base de données publique des médicaments	Identifier(s): 67972497
Country: JP	医薬品医療機器総合機構	Identifier(s): 2492700R1022
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1089151, 1089152
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 205079
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100411390
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W66520001, W66520002
Country: US	FDA, National Drug Code	Identifier(s): 0002-6145